Press Releases AbbVie Inc. London S.E.

Equities

0QCV

US00287Y1091

Market Closed - London S.E. Other stock markets 09:00:00 08/07/2024 pm IST			After market 09:51:05 pm
166.5 ^USD	+1.00%		166.1	-0.24%

02:45pm	That's not so bad, is it?
05/07	Sector Update: Health Care Stocks Steady Premarket Friday	MT

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

AbbVie : Results of Operations and Financial Condition Form 8 K	03/07	PU
AbbVie to Host Second-Quarter 2024 Earnings Conference Call	02/07	PR
Robert A. Michael Assumes Role as AbbVie Chief Executive Officer	01/07	PR
AbbVie - Introducing Alle Payment Plans, Powered by Cherry	28/06	AQ
AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma	28/06	PR
AbbVie Acquires Celsius Therapeutics	27/06	PR
AbbVie - U.S. Food and Drug Administration Grants Second Approval for EPKINLY to Treat Patients with Relapsed or Refractory Follicular Lymphoma	27/06	AQ
Introducing Allē Payment Plans, Powered by Cherry	27/06	PR
U.S. Food and Drug Administration Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Patients with Relapsed or Refractory Follicular Lymphoma	27/06	PR
AbbVie Provides U.S. Regulatory Update on ABBV-951	26/06	AQ
AbbVie Provides U.S. Regulatory Update on ABBV-951 (Foscarbidopa/Foslevodopa)	25/06	PR
AbbVie Declares Quarterly Dividend	24/06	AQ
AbbVie Declares Quarterly Dividend	21/06	PR
AbbVie Appoints Roxanne S. Austin as Lead Independent Director of the Board of Directors	20/06	PR
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio Across Inflammatory Bowel Disease	19/06	PR
AbbVie Recommends Shareholders Reject Tutanota's "Mini-Tender" Offer	15/06	PR
AbbVie and FutureGen Announce License Agreement to Develop Next-Generation Therapy for Inflammatory Bowel Disease	13/06	PR
BOTOX® Cosmetic (onabotulinumtoxinA) Reveals 2024 Women Entrepreneur Grant Recipients	11/06	PR
AbbVie Launches First-of-its-Kind Contest to Empower People Living with Migraine in their Careers	07/06	AQ
AbbVie - SkinMedica Celebrates 25 Years of Empowering Radiant Skin	07/06	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases AbbVie Inc. London S.E.

Equities

0QCV

US00287Y1091

Press Releases

Filters